Dr Reddy's Laboratories Operating Margin 2010-2024 | RDY

Current and historical operating margin for Dr Reddy's Laboratories (RDY) over the last 10 years. The current operating profit margin for Dr Reddy's Laboratories as of September 30, 2024 is 17.81%.
Dr Reddy's Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $3.58B $0.81B 22.54%
2024-06-30 $3.45B $0.81B 23.54%
2024-03-31 $3.35B $0.81B 24.24%
2023-12-31 $3.23B $0.78B 24.00%
2023-09-30 $3.19B $0.77B 24.08%
2023-06-30 $3.15B $0.76B 23.98%
2023-03-31 $2.99B $0.70B 23.23%
2022-12-31 $2.95B $0.57B 19.25%
2022-09-30 $2.83B $0.49B 17.36%
2022-06-30 $2.82B $0.45B 16.08%
2022-03-31 $2.83B $0.39B 13.80%
2021-12-31 $2.83B $0.49B 17.15%
2021-09-30 $2.79B $0.47B 16.93%
2021-06-30 $2.67B $0.43B 16.14%
2021-03-31 $2.59B $0.45B 17.31%
2020-12-31 $2.38B $0.46B 19.13%
2020-09-30 $2.32B $0.45B 19.21%
2020-06-30 $2.34B $0.43B 18.22%
2020-03-31 $2.32B $0.44B 18.78%
2019-12-31 $2.46B $0.41B 16.45%
2019-09-30 $2.38B $0.38B 16.06%
2019-06-30 $2.24B $0.35B 15.63%
2019-03-31 $2.23B $0.30B 13.57%
2018-12-31 $2.15B $0.26B 12.12%
2018-09-30 $2.20B $0.26B 11.72%
2018-06-30 $2.21B $0.25B 11.08%
2018-03-31 $2.18B $0.18B 8.39%
2017-12-31 $2.26B $0.20B 8.75%
2017-09-30 $2.22B $0.21B 9.23%
2017-06-30 $2.21B $0.20B 8.93%
2017-03-31 $2.17B $0.21B 9.58%
2016-12-31 $2.09B $0.22B 10.57%
2016-09-30 $2.15B $0.25B 11.69%
2016-06-30 $2.22B $0.34B 15.43%
2016-03-31 $2.34B $0.45B 19.14%
2015-12-31 $2.43B $0.51B 21.04%
2015-09-30 $2.44B $0.51B 20.98%
2015-06-30 $2.40B $0.46B 19.03%
2015-03-31 $2.40B $0.44B 18.36%
2014-12-31 $2.36B $0.40B 16.82%
2014-09-30 $2.32B $0.41B 17.70%
2014-06-30 $2.27B $0.44B 19.31%
2014-03-31 $2.17B $0.40B 18.37%
2013-12-31 $2.20B $0.41B 18.64%
2013-09-30 $2.15B $0.36B 16.56%
2013-06-30 $2.16B $0.35B 16.27%
2013-03-31 $2.14B $0.36B 16.76%
2012-12-31 $2.05B $0.42B 20.59%
2012-09-30 $2.05B $0.49B 23.86%
2012-06-30 $1.96B $0.42B 21.29%
2012-03-31 $1.95B $0.41B 21.23%
2011-12-31 $1.88B $0.29B 15.42%
2011-09-30 $1.78B $0.21B 11.78%
2011-06-30 $1.74B $0.25B 14.59%
2011-03-31 $1.66B $0.24B 14.52%
2010-12-31 $1.57B $0.19B 11.77%
2010-09-30 $1.52B $0.18B 11.70%
2010-06-30 $1.48B $0.15B 9.78%
2010-03-31 $1.50B $0.16B 10.73%
2009-12-31 $1.53B $0.37B 23.98%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.978B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00